News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis
stock.adobe.com
Jan 25, 2025, 05:02

HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis

Dana-Farber’s Breast Oncology Center shared a post on X about a recent paper by F. Lynce et al. published in ESMO Open:

“Just Published in ESMO Open: HER2DX in HER2-positive Inflammatory Breast Cancer: Correlative insights and comparative analysis with noninflammatory Breast Cancers.”

“HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers”

Authors: F Lynce, O Martínez-Sáez, B Walbaum, A Prat, S M Tolaney et al.

HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis

More posts featuring Dana-Farber’s Breast Oncology Center.

cancer Dana-Farber’s Breast Oncology Center ESMO Open inflammatory breast cancer OncoDaily Oncology
Special Coverage
Insight
Jan 25, 2025, 05:02
HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis
Insight
Jan 25, 2025, 04:58
Al-Ola Abdallah: Myeloma Drug Prices
Dialogues
Jan 25, 2025, 04:54
ASCO24 Updates: Pablo Jiménez-Labaig on Mental Health in Head and Neck Cancer Patients
Insight
Jan 25, 2025, 04:25
New Research to Help GPs Spot Cancer Earlier Using Routine Blood Tests
Insight
Jan 25, 2025, 04:17
Crystal L. Mackall - Candidate for Board of Directors of AACR
Science
Jan 25, 2025, 04:12
Jarushka Naidoo: De-Escalation Strategies With ICIs in NSCLC - Do We Already Have Enough Evidence?
Science
Jan 25, 2025, 04:09
Mohamed Gouda: Selinexor in Combination with Immune Checkpoint Inhibition in Uveal Melanoma
Insight
Jan 25, 2025, 03:54
Chiaojung Jillian Tsai: An outstanding review/editorial on radiotherapy toxicities
Blog
Jan 25, 2025, 03:52
Honored to be endorsed by IASLC for the 3rd year in a row - TLC Conference
Insight
Jan 25, 2025, 03:50
Krishan Jethwa: ESOPEC Pub has landed
Insight
Jan 25, 2025, 03:46
Estela Rodriguez: Using nivolumab plus ipilimumab as a treatment to patients with metastatic NSCLC
Blog
Jan 25, 2025, 03:44
Nicholas Hornstein: NIH-supported activities are being suspended